Answers are grounded in this paper and cite their sources.
Article Tools UNDERSTANDING THE PATHWAY Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study. March 15, 2019 ARTICLE CITATION DOI: 10.1200/JCO.19.00578 Journal of Clinical Oncology - published online before print April 22, 2019 PMID: 31009274 MicroRNA Dysregulation in Malignant Germ Cell Tumors: More Than a Biomarker? Matthew J. Murray, MB BChir, PhD1,2xMatthew J. MurraySearch for articles by this author and Nicholas Coleman, MD, PhD1,2xNicholas ColemanSearch for articles by this author Show More 1University of Cambridge, Cambridge, United Kingdom2Cambridge University Hospitals NHS Foundation Trust, Cambridge, United KingdomM.J.M. and N.C. contributed equally to this work. https://doi.org/10.1200/JCO.19.00578 First Page Full Text PDF Figures and Tables © 2019 by American Society of Clinical Oncology Companion Serum Levels of MicroRNA-371a-3p (M371 Test)
No takes yet. Share an insight, caveat, or question.
Murray et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: